BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15499203)

  • 1. Medical management of urinary stone disease.
    Pak CY
    Nephron Clin Pract; 2004; 98(2):c49-53. PubMed ID: 15499203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
    Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
    J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medical treatment of urinary lithiasis].
    Cachat F; Barbey F; Daudon M
    Rev Med Suisse Romande; 2004 Aug; 124(8):461-4. PubMed ID: 15495468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of medical approach in the management of stone disease.
    Pak CY
    Int J Urol; 1996 Jan; 3(1 Suppl):S63-6. PubMed ID: 24304028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical management of common urinary calculi.
    Pietrow PK; Karellas ME
    Am Fam Physician; 2006 Jul; 74(1):86-94. PubMed ID: 16848382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD
    J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and treatment of pediatric idiopathic urolithiasis-revisited.
    Alon US; Zimmerman H; Alon M
    Pediatr Nephrol; 2004 May; 19(5):516-20. PubMed ID: 15015063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Etiopathogenesis and clinical aspects of nephrolithiasis--at present].
    Ferrari L; Meschi M; Musini S; Frattini A; Savazzi GM
    Recenti Prog Med; 2003 Mar; 94(3):136-41. PubMed ID: 12677782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sodium excretion in children with lithogenic disorders].
    Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
    Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietetic and lifestyle recommendations for stone formers.
    Ferraro PM; Bargagli M
    Arch Esp Urol; 2021 Jan; 74(1):112-122. PubMed ID: 33459627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypercalciuria].
    Wróblewski T; Wystrychowski A
    Przegl Lek; 2011; 68(2):107-13. PubMed ID: 21751520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum for: "Dietetic and lifestyle recommendations for stone formers." (Arch. Esp. Urol. 2021; 74 (1): 112-122).
    Arch Esp Urol; 2021 Oct; 74(8):725-726. PubMed ID: 34605410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enteric and mild hyperoxaluria.
    Sutton RA; Walker VR
    Miner Electrolyte Metab; 1994; 20(6):352-60. PubMed ID: 7783697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
    Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
    Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.